Skip to main content

Karyopharm: Phase 1/3 study of selinexor in combo with rux in treatment-naive patients with MF

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Karyopharm Therapeutics

Start Date

October 10, 2023

End Date

October 14, 2028
 

Administered By

Duke Cancer Institute

Awarded By

Karyopharm Therapeutics

Start Date

October 10, 2023

End Date

October 14, 2028